1-8 of 8
Anna V. Tinker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study

Ana Oaknin, Bhavana Pothuri, Lucy Gilbert, Renaud Sabatier, Jubilee Brown, Sharad Ghamande, Cara Mathews, David M. O'Malley, Rebecca Kristeleit, Valentina Boni, Adriano Gravina, Susana Banerjee, Rowan Miller, Joanna Pikiel, Mansoor R. Mirza, Ninad Dewal, Grace Antony, Yuping Dong, Eleftherios Zografos, Jennifer Veneris, Anna V. Tinker
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (22): 4564–4574.
https://doi.org/10.1158/1078-0432.CCR-22-3915
Published: 14 November 2023
View article titled, Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Open the PDF for Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study in another window
Includes: Supplementary data
Journal Articles

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma

Pauline Krämer, Aline Talhouk, Mary Anne Brett, Derek S. Chiu, Evan S. Cairns, Daniëlla A. Scheunhage, Rory F.L. Hammond, David Farnell, Tayyebeh M. Nazeran, Marcel Grube, Zhouchunyang Xia, Janine Senz, Samuel Leung, Lukas Feil, Jana Pasternak, Katherine Dixon, Andreas Hartkopf, Bernhard Krämer, Sara Brucker, Florian Heitz, Andreas du Bois, Philipp Harter, Felix K.F. Kommoss, Hans-Peter Sinn, Sabine Heublein, Friedrich Kommoss, Hans-Walter Vollert, Ranjit Manchanda, Cornelis D. de Kroon, Hans W. Nijman, Marco de Bruyn, Emily F. Thompson, Ali Bashashati, Jessica N. McAlpine, Naveena Singh, Anna V. Tinker, Annette Staebler, Tjalling Bosse, Stefan Kommoss, Martin Köbel, Michael S. Anglesio
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5400–5410.
https://doi.org/10.1158/1078-0432.CCR-20-1268
Published: 15 October 2020
View article titled, Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Open the PDF for Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma in another window
Includes: Supplementary data
Journal Articles

Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221

Anna V. Tinker, Holger W. Hirte, Diane Provencher, Marcus Butler, Heather Ritter, Dongsheng Tu, Hatem A. Azim, Jr, Paulo Paralejas, Nathalie Grenier, Shirley-Ann Hahn, Janelle Ramsahai, Lesley Seymour
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (20): 6052–6060.
https://doi.org/10.1158/1078-0432.CCR-19-0298
Published: 15 October 2019
View article titled, Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221
Open the PDF for Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221 in another window
Includes: Supplementary data
Journal Articles

Abstract AP28: BRCA1 and RAD51C Promoter Hypermethylation Confer Sensitivity to PARP Inhibitors in Patients with Platinum Sensitive Ovarian Carcinoma

Elizabeth Swisher, Maria Harrell, Kevin K. Lin, Clare Scott, Sandra Goble, Amit Oza, Robert L. Coleman, Gottfried Konecny, Anna V. Tinker, David M. O'Malley, Rebecca Kristeleit, Ling Ma, James Brenton, Katherine Bell-McGuinn, Ana Oaknin, Alexandra Leary, Elaina Mann, Heidi Giordano, Mitch Rapon, Iain McNeish, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): AP28.
https://doi.org/10.1158/1557-3265.OVCASYMP16-AP28
Published: 31 May 2017
View article titled, Abstract AP28: <em>BRCA1</em> and <em>RAD51C</em> Promoter Hypermethylation Confer Sensitivity to PARP Inhibitors in Patients with Platinum Sensitive Ovarian Carcinoma
Journal Articles

Abstract A11: NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib.

Iain A. McNeish, Kevin K. Lin, James X. Sun, Sandra Goble, Amit Oza, Robert L. Coleman, Clare L. Scott, Gottfried Konecny, Anna V. Tinker, David M. O'Malley, Rebecca Kristeleit, Ling Ma, James D. Brenton, Katherine Bell-McGuinn, Ana Oaknin, Alexandra Leary, Elaina Mann, Heidi Giordano, Roman Yelensky, Mitch Raponi, Elizabeth Swisher
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A11.
https://doi.org/10.1158/1557-3265.OVCA15-A11
Published: 15 January 2016
View article titled, Abstract A11: NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib.
Journal Articles

Abstract A18: Defining ovarian mucinous tumors: Cancer genes and heterogeneity

Michael S. Anglesio, Robertson Mackenzie, Stefan Kommoss, Boris J. Winterhoff, Benjamin Kipp, Jaoquin Garcia, Jesse S. Voss, Kevin Halling, Sarah Kerr, Janine Senz, Winnie Yang, Magnus von Knebel Doeberitz, Elena-Sophie Prigge, Miriam Reuschenbach, Anna V. Tinker, Blake Gilks, Jamie N. Bakkum-Gamez, David G. Huntsman, Jessica N. McAlpine
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A18.
https://doi.org/10.1158/1078-0432.OVCA13-A18
Published: 13 May 2014
View article titled, Abstract A18: Defining ovarian mucinous tumors: Cancer genes and heterogeneity
Journal Articles

Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

Dariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, Craig Mermel, Joshy George, Gad Getz, Richard Tothill, Aikou Okamoto, Maria B. Raeder, AOCS Study Group, Paul Harnett, Stephen Lade, Lars A. Akslen, Anna V. Tinker, Bianca Locandro, Kathryn Alsop, Yoke-Eng Chiew, Nadia Traficante, Sian Fereday, Daryl Johnson, Stephen Fox, William Sellers, Mitsuyoshi Urashima, Helga B. Salvesen, Matthew Meyerson, David Bowtell
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1417–1427.
https://doi.org/10.1158/1078-0432.CCR-08-1564
Published: 19 February 2009
View article titled, Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
Open the PDF for Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas in another window
Includes: Supplementary data
Journal Articles

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

Richard W. Tothill, Anna V. Tinker, Joshy George, Robert Brown, Stephen B. Fox, Stephen Lade, Daryl S. Johnson, Melanie K. Trivett, Dariush Etemadmoghadam, Bianca Locandro, Nadia Traficante, Sian Fereday, Jillian A. Hung, Yoke-Eng Chiew, Izhak Haviv, Australian Ovarian Cancer Study Group, Dorota Gertig, Anna deFazio, David D.L. Bowtell
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5198–5208.
https://doi.org/10.1158/1078-0432.CCR-08-0196
Published: 12 August 2008
View article titled, Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Open the PDF for Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome in another window
Includes: Supplementary data